Robel Getachew
Impact in
- Immunology and Allergy top 5%
- Cell Adhesion Molecules Research
- Cell Biology top 10%
- Proteoglycans and glycosaminoglycans research
Papers in
-
- Cell Adhesion Molecules Research 4
-
- Proteoglycans and glycosaminoglycans research 7
- Co-authors
- Peter J. LittleNarin OsmanMicah L. BurchMandy L. BallingerWenhua ZhengSundy N.Y. YangDanielle KamatoMark A. Febbraio
- Journals
- Journal of Pharmacy and Pharmacology (4 papers)Journal of Biological Chemistry (3 papers)Cellular Signalling (2 papers)Cardiovascular Pathology (1 paper)Journal of Pharmacology and Experimental Therapeutics (1 paper)
- Partner nations
- AustraliaChinaUnited States
In The Last Decade
Robel Getachew
25 papers receiving 734 citations
Peers
Comparison fields: 5 of 75
- Immunology and Allergy 129
- Cell Biology 117
- Molecular Biology 447
- Immunology 128
- Cancer Research 82
Countries citing papers authored by Robel Getachew
This map shows the geographic impact of Robel Getachew's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Robel Getachew with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Robel Getachew more than expected).
Fields of papers citing papers by Robel Getachew
This network shows the impact of papers produced by Robel Getachew. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Robel Getachew. The network helps show where Robel Getachew may publish in the future.
Co-authors
The 25 scholars most cited alongside Robel Getachew, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2018 | 24 | |
| 2 | 2016 | 4 | |
| 3 | 2016 | 1 | |
| 4 | 2016 | 8 | |
| 5 | 2015 | 38 | |
| 6 | Methotrexate inhibits proliferation but notproteoglycan synthesis or glycosaminoglycan hyperelongationin human vascular smooth muscle cells | 2015 | 1 |
| 7 | 2014 | 11 | |
| 8 | 2014 | 75 | |
| 9 | 2013 | 52 | |
| 10 | 2012 | 22 | |
| 11 | 2012 | 12 | |
| 12 | 2012 | 26 | |
| 13 | 2011 | 20 | |
| 14 | 2010 | 70 | |
| 15 | 2010 | 0 | |
| 16 | 2010 | 53 | |
| 17 | 2009 | 17 | |
| 18 | 2009 | 18 | |
| 19 | 2008 | 58 | |
| 20 | 2008 | 11 |
About Robel Getachew
Robel Getachew is a scholar working on Immunology and Allergy, Cell Biology, Molecular Biology, Cancer Research and Hepatology, having authored 26 papers that have together received 736 indexed citations. Recurring topics across this work include TGF-β signaling in diseases (8 papers), Proteoglycans and glycosaminoglycans research (7 papers), Protein Kinase Regulation and GTPase Signaling (5 papers), Glycosylation and Glycoproteins Research (4 papers), Cell Adhesion Molecules Research (4 papers), Receptor Mechanisms and Signaling (3 papers), Protease and Inhibitor Mechanisms (3 papers) and Metabolism, Diabetes, and Cancer (3 papers). The work is most often cited by research in Immunology and Allergy (129 citations), Cell Biology (117 citations), Molecular Biology (447 citations), Immunology (128 citations) and Cancer Research (82 citations). Robel Getachew has collaborated with scholars based in Australia, China and United States. Frequent co-authors include Peter J. Little, Narin Osman, Micah L. Burch, Mandy L. Ballinger, Wenhua Zheng, Sundy N.Y. Yang, Danielle Kamato, Mark A. Febbraio, Kate L. Loveland and Catherine Itman. Their work appears in journals such as Journal of Pharmacy and Pharmacology, Journal of Biological Chemistry, Cellular Signalling, Cardiovascular Pathology and Journal of Pharmacology and Experimental Therapeutics.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.